SIGYN THERAPEUTICS, INC. (SIGY) Free cash flow 2015–2023
SIGYN THERAPEUTICS, INC. (SIGY) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.4MFY2023 · since FY2015: -$87,285 → -$1.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$1.4M | +25.6% |
| FY2022 | -$1.9M | — |
| FY2019 | -$146,634 | +48.9% |
| FY2018 | -$287,052 | — |
| FY2015 | -$87,285 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SIGY financial trends
SIGY RevenueSIGY Net incomeSIGY Net marginSIGY Gross profitSIGY Gross marginSIGY Operating incomeSIGY Operating marginSIGY Operating cash flowSIGY Capital expendituresSIGY Return on equitySIGY Stock buybacksSIGY Dividends paidSIGY Total assetsSIGY Total liabilitiesSIGY Shareholders’ equitySIGY overview →